English

    Overview

  • Dr. Harsh Dhar is a highly respected oncologist with over a decade of clinical and surgical experience, currently practicing at Manipal Hospitals Broadway. He specialises in the management of complex head and neck malignancies, including thyroid tumours and cancers of the oral cavity, salivary glands, paranasal sinuses, and larynx. His meticulous approach, surgical precision, and patient-centric care have earned him the trust of countless patients and the recognition of peers across India and abroad.

  • A board-certified oncologist, Dr. Dhar completed his MBBS from one of the world's leading medical universities. He further trained in surgical oncology, with a focused interest in head and neck cancers, earning a Gold Medal from the esteemed Tata Memorial Hospital in 2017 — one of the highest accolades in his field. His academic brilliance also earned him the MUHS Silver Medal in MS ENT and a Silver Medal in ENT during his MBBS.

  • Throughout his medical journey, Dr. Dhar has actively engaged in clinical research, particularly exploring the role of Neoadjuvant chemotherapy in oral malignancies. His contributions have added value to evolving treatment protocols aimed at preserving organ function and improving patient outcomes. He has independently performed and assisted in a wide range of complex surgeries, including those involving paragangliomas, thyroid, sinonasal tumours, and oral cancers.

  • Dr. Dhar is also a passionate educator and has delivered several invited lectures at regional and national-level conferences. His ability to simplify complex concepts and communicate effectively makes him a valuable mentor and speaker in medical forums.

  • He is an active member of several prestigious professional bodies, including the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology. These affiliations reflect his global outlook, commitment to continued learning, and adherence to the latest standards in cancer care. He is the Best Surgical Oncologist in Broadway, Kolkata.

  • With a strong foundation in evidence-based medicine, compassionate patient engagement, and academic excellence, Dr. Harsh Dhar continues to make significant contributions to the field of oncology, particularly in the subspecialty of head and neck cancers. His goal remains simple yet powerful—to provide holistic, precise, and effective cancer care that restores both health and hope.

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients. Click Here
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529. Click Here
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001. Click Here
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110. Click Here
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249. Click Here
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563. Click Here
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017. Click Here
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015. Click Here
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital). Click Here
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition. Click Here
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542. Click Here
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69. Click Here
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5. Click Here
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455. Click Here
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662. Click Here
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4. Click Here
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6. Click Here
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5. Click Here
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814. Click Here
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019. Click Here

    Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Overview

  • Dr. Harsh Dhar is a highly respected oncologist with over a decade of clinical and surgical experience, currently practicing at Manipal Hospitals Broadway. He specialises in the management of complex head and neck malignancies, including thyroid tumours and cancers of the oral cavity, salivary glands, paranasal sinuses, and larynx. His meticulous approach, surgical precision, and patient-centric care have earned him the trust of countless patients and the recognition of peers across India and abroad.

  • A board-certified oncologist, Dr. Dhar completed his MBBS from one of the world's leading medical universities. He further trained in surgical oncology, with a focused interest in head and neck cancers, earning a Gold Medal from the esteemed Tata Memorial Hospital in 2017 — one of the highest accolades in his field. His academic brilliance also earned him the MUHS Silver Medal in MS ENT and a Silver Medal in ENT during his MBBS.

  • Throughout his medical journey, Dr. Dhar has actively engaged in clinical research, particularly exploring the role of Neoadjuvant chemotherapy in oral malignancies. His contributions have added value to evolving treatment protocols aimed at preserving organ function and improving patient outcomes. He has independently performed and assisted in a wide range of complex surgeries, including those involving paragangliomas, thyroid, sinonasal tumours, and oral cancers.

  • Dr. Dhar is also a passionate educator and has delivered several invited lectures at regional and national-level conferences. His ability to simplify complex concepts and communicate effectively makes him a valuable mentor and speaker in medical forums.

  • He is an active member of several prestigious professional bodies, including the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology. These affiliations reflect his global outlook, commitment to continued learning, and adherence to the latest standards in cancer care. He is the Best Surgical Oncologist in Broadway, Kolkata.

  • With a strong foundation in evidence-based medicine, compassionate patient engagement, and academic excellence, Dr. Harsh Dhar continues to make significant contributions to the field of oncology, particularly in the subspecialty of head and neck cancers. His goal remains simple yet powerful—to provide holistic, precise, and effective cancer care that restores both health and hope.

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients. Click Here
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529. Click Here
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001. Click Here
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110. Click Here
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249. Click Here
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563. Click Here
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017. Click Here
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015. Click Here
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital). Click Here
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition. Click Here
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542. Click Here
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69. Click Here
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5. Click Here
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455. Click Here
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662. Click Here
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4. Click Here
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6. Click Here
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5. Click Here
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814. Click Here
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019. Click Here

    Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Overview

  • Dr. Harsh Dhar is a highly respected oncologist with over a decade of clinical and surgical experience, currently practicing at Manipal Hospitals Broadway. He specialises in the management of complex head and neck malignancies, including thyroid tumours and cancers of the oral cavity, salivary glands, paranasal sinuses, and larynx. His meticulous approach, surgical precision, and patient-centric care have earned him the trust of countless patients and the recognition of peers across India and abroad.

  • A board-certified oncologist, Dr. Dhar completed his MBBS from one of the world's leading medical universities. He further trained in surgical oncology, with a focused interest in head and neck cancers, earning a Gold Medal from the esteemed Tata Memorial Hospital in 2017 — one of the highest accolades in his field. His academic brilliance also earned him the MUHS Silver Medal in MS ENT and a Silver Medal in ENT during his MBBS.

  • Throughout his medical journey, Dr. Dhar has actively engaged in clinical research, particularly exploring the role of Neoadjuvant chemotherapy in oral malignancies. His contributions have added value to evolving treatment protocols aimed at preserving organ function and improving patient outcomes. He has independently performed and assisted in a wide range of complex surgeries, including those involving paragangliomas, thyroid, sinonasal tumours, and oral cancers.

  • Dr. Dhar is also a passionate educator and has delivered several invited lectures at regional and national-level conferences. His ability to simplify complex concepts and communicate effectively makes him a valuable mentor and speaker in medical forums.

  • He is an active member of several prestigious professional bodies, including the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology. These affiliations reflect his global outlook, commitment to continued learning, and adherence to the latest standards in cancer care. He is the Best Surgical Oncologist in Broadway, Kolkata.

  • With a strong foundation in evidence-based medicine, compassionate patient engagement, and academic excellence, Dr. Harsh Dhar continues to make significant contributions to the field of oncology, particularly in the subspecialty of head and neck cancers. His goal remains simple yet powerful—to provide holistic, precise, and effective cancer care that restores both health and hope.

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients. Click Here
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529. Click Here
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001. Click Here
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110. Click Here
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249. Click Here
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563. Click Here
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017. Click Here
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015. Click Here
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital). Click Here
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition. Click Here
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542. Click Here
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69. Click Here
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5. Click Here
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455. Click Here
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662. Click Here
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4. Click Here
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6. Click Here
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5. Click Here
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814. Click Here
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019. Click Here

    Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients. Click Here
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529. Click Here
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001. Click Here
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110. Click Here
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249. Click Here
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563. Click Here
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017. Click Here
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015. Click Here
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital). Click Here
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition. Click Here
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542. Click Here
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69. Click Here
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5. Click Here
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455. Click Here
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662. Click Here
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4. Click Here
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6. Click Here
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5. Click Here
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814. Click Here
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019. Click Here

    • Overview

  • Dr. Harsh Dhar is a highly respected oncologist with over a decade of clinical and surgical experience, currently practicing at Manipal Hospitals Broadway. He specialises in the management of complex head and neck malignancies, including thyroid tumours and cancers of the oral cavity, salivary glands, paranasal sinuses, and larynx. His meticulous approach, surgical precision, and patient-centric care have earned him the trust of countless patients and the recognition of peers across India and abroad.

  • A board-certified oncologist, Dr. Dhar completed his MBBS from one of the world's leading medical universities. He further trained in surgical oncology, with a focused interest in head and neck cancers, earning a Gold Medal from the esteemed Tata Memorial Hospital in 2017 — one of the highest accolades in his field. His academic brilliance also earned him the MUHS Silver Medal in MS ENT and a Silver Medal in ENT during his MBBS.

  • Throughout his medical journey, Dr. Dhar has actively engaged in clinical research, particularly exploring the role of Neoadjuvant chemotherapy in oral malignancies. His contributions have added value to evolving treatment protocols aimed at preserving organ function and improving patient outcomes. He has independently performed and assisted in a wide range of complex surgeries, including those involving paragangliomas, thyroid, sinonasal tumours, and oral cancers.

  • Dr. Dhar is also a passionate educator and has delivered several invited lectures at regional and national-level conferences. His ability to simplify complex concepts and communicate effectively makes him a valuable mentor and speaker in medical forums.

  • He is an active member of several prestigious professional bodies, including the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology. These affiliations reflect his global outlook, commitment to continued learning, and adherence to the latest standards in cancer care. He is the Best Surgical Oncologist in Broadway, Kolkata.

  • With a strong foundation in evidence-based medicine, compassionate patient engagement, and academic excellence, Dr. Harsh Dhar continues to make significant contributions to the field of oncology, particularly in the subspecialty of head and neck cancers. His goal remains simple yet powerful—to provide holistic, precise, and effective cancer care that restores both health and hope.

    Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients. Click Here
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529. Click Here
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001. Click Here
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110. Click Here
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249. Click Here
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563. Click Here
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017. Click Here
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015. Click Here
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital). Click Here
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition. Click Here
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542. Click Here
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69. Click Here
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5. Click Here
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455. Click Here
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662. Click Here
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4. Click Here
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6. Click Here
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5. Click Here
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814. Click Here
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019. Click Here

    • Overview

  • Dr. Harsh Dhar is a highly respected oncologist with over a decade of clinical and surgical experience, currently practicing at Manipal Hospitals Broadway. He specialises in the management of complex head and neck malignancies, including thyroid tumours and cancers of the oral cavity, salivary glands, paranasal sinuses, and larynx. His meticulous approach, surgical precision, and patient-centric care have earned him the trust of countless patients and the recognition of peers across India and abroad.

  • A board-certified oncologist, Dr. Dhar completed his MBBS from one of the world's leading medical universities. He further trained in surgical oncology, with a focused interest in head and neck cancers, earning a Gold Medal from the esteemed Tata Memorial Hospital in 2017 — one of the highest accolades in his field. His academic brilliance also earned him the MUHS Silver Medal in MS ENT and a Silver Medal in ENT during his MBBS.

  • Throughout his medical journey, Dr. Dhar has actively engaged in clinical research, particularly exploring the role of Neoadjuvant chemotherapy in oral malignancies. His contributions have added value to evolving treatment protocols aimed at preserving organ function and improving patient outcomes. He has independently performed and assisted in a wide range of complex surgeries, including those involving paragangliomas, thyroid, sinonasal tumours, and oral cancers.

  • Dr. Dhar is also a passionate educator and has delivered several invited lectures at regional and national-level conferences. His ability to simplify complex concepts and communicate effectively makes him a valuable mentor and speaker in medical forums.

  • He is an active member of several prestigious professional bodies, including the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology. These affiliations reflect his global outlook, commitment to continued learning, and adherence to the latest standards in cancer care. He is the Best Surgical Oncologist in Broadway, Kolkata.

  • With a strong foundation in evidence-based medicine, compassionate patient engagement, and academic excellence, Dr. Harsh Dhar continues to make significant contributions to the field of oncology, particularly in the subspecialty of head and neck cancers. His goal remains simple yet powerful—to provide holistic, precise, and effective cancer care that restores both health and hope.

    Talks & Publications

  • Dr. Dhar has actively contributed to clinical research, with a focus on Neoadjuvant Chemotherapy in Oral Malignancies. His work supports organ preservation strategies and improves the quality of life for cancer patients. Click Here
  • Lodha JV1, Dabholkar JP, Dhar H ; Fronto-ethmoid osteoma: addressing surgical challenges. J Postgrad Med. 2014 Apr-Jun;60(2):207-8. PMID:24823529. Click Here
  • Dhar H, Dabholkar JP, Kandalkar BM, Ghodke R. Primary thyroid schwannoma masquerading as a thyroid nodule. J Surg Case Rep. 2014 Sep 23;2014(9) PMID: 25249001. Click Here
  • Tuljapurkar V, Dhar H, Mishra A, Chakraborti S, Chaturvedi P, Pai PS. The Indian scenario of head and neck oncology – Challenging the dogmas. South Asian Journal of Cancer. 2016;5(3):105-110. Click Here
  • Vaish R, Dhar H, DCruz A K .“Beyond Me, Too”. Journal of Global Oncology 2, no. 4 (August 2016) 248-249. Click Here
  • Dandekar M, Tuljapurkar V, Dhar H, Panwar A, DCruz A K. Head and neck cancers in India. J Surg Oncol. 2017; 115:555–563. Click Here
  • Dhar H, Thiagarajan S . Anomalous Radial Artery Bifurcation – Case report of 2 cases encountered during Radial Artery Forearm Flap Harvest. Images in Surgery, 2017. Click Here
  • Dhar H, Deshmukh A. Basic Principles in Laser Surgery -Chapter in Handbook of Laser Surgery, published by Lumenis, October 2015. Click Here
  • Deshmukh A, Mair M, Dhar H Surgeries for Tongue Cancer -chapter in Atlas of Operative Surgical Oncology, 2016 (published by the Tata Memorial Hospital). Click Here
  • DCruz A K , Dhar H , Mair M , Stack B . Elective Neck Dissection in the Upper Aerodigestive Tract. Chapter in Journal of ENT Master Class special edition. Click Here
  • Dabholkar J, Sharma A, Virmani N, Dhar H. Management of benign laryngotracheal stenosis – A 5-year experience of Indian tertiary care setup. J Head Neck Physicians Surg 2018; 6:3542. Click Here
  • D'Cruz AK, Vaish R, Dhar H. Oral cancers: Current status. Oral Oncol. 2018 Dec; 87:64-69. Click Here
  • Utility of response assessment PET-CT to predict residual disease in neck nodes: A comparison with the Histopathology.Fatehi KS, Thiagarajan S, Dhar H, Purandare N, DCruz AK, Chaukar D, Laskar SG, Prabhash K, Rangarajan V.Auris Nasus Larynx. 2018 Dec 26. pii: S0385-8146(18)30620-5. Click Here
  • Thiagarajan S, Dhar H, Bhattacharjee A, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to NeoAdjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral Oncol. 2020;100:104455. doi:10.1016/j.oraloncology.2019.104455. Click Here
  • Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol. 2020;105:104662. doi:10.1016/j.oraloncology.2020.104662. Click Here
  • Dhar, H., Thiagarajan, S., Yousuf, A. et al. Referral Practice for Radioactive Iodine Ablation. (RAI) after ATA guidelines 2015: results from a Tertiary Cancer Care Centre. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05946-4. Click Here
  • Dhar H, Datta S. Experience of treating head and neck cancers in government and private health-care systems during the COVID-19 pandemic: A viewpoint with summary of existing guidelines. Cancer Res Stat Treat 2020;3, Suppl S1:123-6. Click Here
  • Balaji, A., Thiagarajan, S., Dhar, H. et al. The results of sequential swallowing assessments after total laryngectomy for laryngeal and hypopharyngeal malignancies. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-06105-5. Click Here
  • S Thiagarajan , A Yousuf , R Shetty , H Dhar , Y Mathur , D Nair , S Basu , A Patil , S Kane , S Ghosh-Laskar , D Chaukar. Poorly differentiated thyroid carcinoma (PDTC) characteristics and the efficacy of radioactive iodine (RAI) therapy as an adjuvant treatment in a tertiary cancer care centre . Eur Arch Otorhinolaryngol. 2020;277(6):1807‐1814. Click Here
  • Chapter: Elective Versus Therapeutic Neck Dissection for Clinically.Node Negative Early oral Cancer, D’Cruz A K, Dhar H, Vaish R .Difficult Decisions in Head and Neck Oncologic Surgery edited by Zhen Gooi, Nishant Agrawal, Springer 2019. Click Here

    • Overview

  • Dr. Harsh Dhar is a highly respected oncologist with over a decade of clinical and surgical experience, currently practicing at Manipal Hospitals Broadway. He specialises in the management of complex head and neck malignancies, including thyroid tumours and cancers of the oral cavity, salivary glands, paranasal sinuses, and larynx. His meticulous approach, surgical precision, and patient-centric care have earned him the trust of countless patients and the recognition of peers across India and abroad.

  • A board-certified oncologist, Dr. Dhar completed his MBBS from one of the world's leading medical universities. He further trained in surgical oncology, with a focused interest in head and neck cancers, earning a Gold Medal from the esteemed Tata Memorial Hospital in 2017 — one of the highest accolades in his field. His academic brilliance also earned him the MUHS Silver Medal in MS ENT and a Silver Medal in ENT during his MBBS.

  • Throughout his medical journey, Dr. Dhar has actively engaged in clinical research, particularly exploring the role of Neoadjuvant chemotherapy in oral malignancies. His contributions have added value to evolving treatment protocols aimed at preserving organ function and improving patient outcomes. He has independently performed and assisted in a wide range of complex surgeries, including those involving paragangliomas, thyroid, sinonasal tumours, and oral cancers.

  • Dr. Dhar is also a passionate educator and has delivered several invited lectures at regional and national-level conferences. His ability to simplify complex concepts and communicate effectively makes him a valuable mentor and speaker in medical forums.

  • He is an active member of several prestigious professional bodies, including the Foundation of Head and Neck Oncology, the Indian Society of Thyroid Surgeons, the Asia Pacific Thyroid Society, and the European Society of Medical Oncology. These affiliations reflect his global outlook, commitment to continued learning, and adherence to the latest standards in cancer care. He is the Best Surgical Oncologist in Broadway, Kolkata.

  • With a strong foundation in evidence-based medicine, compassionate patient engagement, and academic excellence, Dr. Harsh Dhar continues to make significant contributions to the field of oncology, particularly in the subspecialty of head and neck cancers. His goal remains simple yet powerful—to provide holistic, precise, and effective cancer care that restores both health and hope.

    • Fellowship & Membership

  • Member of the Foundation of Head and Neck Oncology
  • Member of the Indian Society of Thyroid Surgeons
  • Member of the Asia Pacific Thyroid Society
  • Member of the European Society of Medical Oncology

    • Field of Expertise

  • All Types of Head and Neck Malignancies
  • Thyroid Tumors

    • Languages Spoken

  • English
  • Hindi
  • Bengali
  • Marathi
  • Tamil

    • Awards & Achievements

  • Gold Medal in Surgical Oncology, Batch of 2017, Tata Memorial Hospital
  • Silver Medal in ENT, MBBS (III Year)
  • MUHS Silver Medicine in MS ENT
  • MGR Medical University Silver Medal in Internal Medicine -Batch of 2009

FAQ's

Patients visit Dr. Harsh Dhar, a leading Senior Consultant - Surgical Oncology at Manipal Hospitals Broadway - Kolkata, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Harsh Dhar is a trusted choice for exceptional medical support.

Home Broadway Doctors Dr-harsh-dhar-oncologist

You’re on Our Indian Website

Visit the Global site for International patient services

Appointment
Health Check
Contact Us
review icon
Review Us
Call Us